Topical application of dehydroxymethylepoxyquinomicin improves allergic inflammation via NF-kappaB inhibition.
Hamasaka
Asuka
A
Yoshioka
Naoya
N
Abe
Riichiro
R
Kishino
Satoshi
S
Umezawa
Kazuo
K
Ozaki
Michitaka
M
Todo
Satoru
S
Shimizu
Hiroshi
H
D021581:Active Transport, Cell Nucleus / Q000187:drug effects; D000287:Administration, Topical; D000818:Animals; D001549:Benzamides / Q000494:pharmacology*; D002460:Cell Line; D003512:Cyclohexanones / Q000494:pharmacology*; D003876:Dermatitis, Atopic / Q000188:drug therapy* / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D004195:Disease Models, Animal; D006801:Humans; D051379:Mice; D016328:NF-kappa B / Q000037:antagonists & inhibitors* / Q000378:metabolism*
D001549:Benzamides; D003512:Cyclohexanones; D016328:NF-kappa B; C464444:dehydroxymethylepoxyquinomicin